InsiderFlow

ROIV

Roivant Sciences Ltd.$27.82+0.00 (+0.00%)
Prev Close$27.85·MCap$20.96B·P/E·Vol2.05M·Yield

Buys (12M)

1

$350.00M

Sells (12M)

2

$87.34M

Net Activity

Net Buyer

$262.66M

Active Insiders

3

last 12 mo

Over the past 12 months, insider activity at Roivant Sciences Ltd. (ROIV) has been dominated by buying, with 1 insider purchase totaling $350.00M and 2 insider sales totaling $87.34M. The most recent insider transaction was by Torti Frank (President and Vant Chair), who sold $82.04M worth of shares on Feb 19, 2026. Roivant Sciences Ltd. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $20.96B.

ROIV Insider Trading Activity

DateInsiderTypeValue
Feb 19, 2026 Torti FrankSell$82.04M
Feb 13, 2026 Venker EricSell$5.30M
Dec 12, 2025 Roivant Sciences Ltd.Buy$350.00M2.3% OS

ROIV Insider Buying Activity

The following table shows recent insider purchases of Roivant Sciences Ltd. (ROIV) stock reported via SEC Form 4 filings.

DateInsiderTypeValue
Dec 12, 2025 Roivant Sciences Ltd.Buy$350.00M2.3% OS

ROIV Insider Selling Activity

The following table shows recent insider sales of Roivant Sciences Ltd. (ROIV) stock reported via SEC Form 4 filings.

DateInsiderTypeValue
Feb 19, 2026 Torti FrankSell$82.04M
Feb 13, 2026 Venker EricSell$5.30M

ROIV Insiders

Torti Frank

President and Vant Chair

Sold $82.04M
1 tradesLast: Feb 19, 2026
Venker Eric

President & Immunovant CEO

Sold $5.30M
1 tradesLast: Feb 13, 2026
Roivant Sciences Ltd.

Bought $350.00M
1 tradesLast: Dec 12, 2025